Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.


Journal

Biointerphases
ISSN: 1559-4106
Titre abrégé: Biointerphases
Pays: United States
ID NLM: 101275679

Informations de publication

Date de publication:
25 03 2021
Historique:
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 25 12 2021
Statut: epublish

Résumé

The blood-brain barrier (BBB) maintains the homeostasis of the central nervous system, which is one of the reasons for the treatments of brain disorders being challenging in nature. Nanoparticles (NPs) have been seen as potential drug delivery systems to the brain overcoming the tight barrier of endothelial cells. Using a BBB model system based on human induced pluripotent stem cells (iPSCs), the impact of polymeric nanoparticles has been studied in relation to nanoparticle size, material, and protein corona. PLGA [poly(lactic-co-glycolic acid)] and PLLA [poly(d,l-lactide)] nanoparticles stabilized with Tween® 80 were synthesized (50 and 100 nm). iPSCs were differentiated into human brain microvascular endothelial cells (hBMECs), which express prominent BBB features, and a tight barrier was established with a high transendothelial electrical resistance of up to 4000 Ω cm

Identifiants

pubmed: 33765771
doi: 10.1116/6.0000889
doi:

Substances chimiques

Polymers 0
Polystyrenes 0
Protein Corona 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

021004

Auteurs

Helen N Onyema (HN)

Fraunhofer Institute for Microengineering and Microsystems, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany.

Martin Berger (M)

Department of Chemistry, Johannes Gutenberg-University Mainz, Saarstr. 21, 55122 Mainz, Germany.

Anna Musyanovych (A)

Fraunhofer Institute for Microengineering and Microsystems, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany.

Christoph Bantz (C)

Fraunhofer Institute for Microengineering and Microsystems, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany.

Michael Maskos (M)

Fraunhofer Institute for Microengineering and Microsystems, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany.

Christian Freese (C)

Fraunhofer Institute for Microengineering and Microsystems, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH